Mechanism of disulfiram inhibition of P450 2E1 in human liver microsomes
Numerous environmental contaminants and some therapeutic drugs can cause hepatotoxicity when metabolized by cytochrome P450 2E1. Disulfiram and its primary metabolite diethydithiocarbamate (DDTC) inhibit P450 2E1 in vitro and in vivo, and disulfiram may prevent metabolism-based toxicity. Disulfiram and DDTC are mechanism-based inhibitors requiring P450 2E1-mediated activation to the ultimate inhibitory species. Disulfiram is extensively metabolized in vivo, however, the identity of the most inhibitory disulfiram metabolite is unknown. This project tests the hypothesis that disulfiram metabolites is/are the ultimate species responsible for P450 2E1 inhibition. Human liver microsomal P450 2E1 activity was determined by chlorzoxazone 6-hydroxylation, in the presence and absence (controls) of the disulfiram metabolites: DDTC, S-methyl-N, N-diethyldithio-carbamate (DDTC-Me) S-methyl-N, N-diethylthiocarbamate (DETC-Me), S-methyl-N, N-diethylthiocarbamate sulfoxide (DETC-MeSO) S-methyl-N, N-diethyldithiocarbamate sulfoxide (DDTC-MeSO), S-methyl-N, N-diethylthiocarbamate sulfone (DETC-MeSO
Duke Scholars
Published In
ISSN
Publication Date
Volume
Issue
Start / End Page
Related Subject Headings
- General Clinical Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
Published In
ISSN
Publication Date
Volume
Issue
Start / End Page
Related Subject Headings
- General Clinical Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences